Atorvastatin (Xalipmin, Cholmin, Lipred)
Atorvastatin
Trinity Pharma (Pty) Ltd
Registration
- Applicant
- Trinity Pharma (Pty) Ltd
- Certificate holder
- Trinity Pharma (Pty) Ltd
- Registrations
- 12
- Schedule source
- SAHPRA documentation
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Xalipmin 10 | 10/20/40/80 mgFilm-coated tablets | 49047749/7.5/0477Approved 28 July 2025 | Registered | S4 | PIPIL |
| Xalipmin 20 | 10/20/40/80 mgFilm-coated tablets | 49047849/7.5/0478Approved 28 July 2025 | Registered | S4 | PIPIL |
| Xalipmin 40 | 10/20/40/80 mgFilm-coated tablets | 49047949/7.5/0479Approved 28 July 2025 | Registered | S4 | PIPIL |
| Xalipmin 80 | 10/20/40/80 mgFilm-coated tablets | 49048049/7.5/0480Approved 28 July 2025 | Registered | S4 | PIPIL |
| Cholmin 10 | 0/20/40/80 mgFilm-coated tablets | 49048149/7.5/0481Approved 28 July 2025 | Registered | S4 | PIPIL |
| Cholmin 20 | 0/20/40/80 mgFilm-coated tablets | 49048249/7.5/0482Approved 28 July 2025 | Registered | S4 | PIPIL |
| Cholmin 40 | 0/20/40/80 mgFilm-coated tablets | 49048349/7.5/0483Approved 28 July 2025 | Registered | S4 | PIPIL |
| Cholmin 80 | 0/20/40/80 mgFilm-coated tablets | 49048449/7.5/0484Approved 28 July 2025 | Registered | S4 | PIPIL |
| Lipred 10 | 10/20/40/80 mgFilm-coated tablets | 49048549/7.5/0485Approved 28 July 2025 | Registered | S4 | PIPIL |
| Lipred 20 | 10/20/40/80 mgFilm-coated tablets | 49048649/7.5/0486Approved 28 July 2025 | Registered | S4 | PIPIL |
| Lipred 40 | 10/20/40/80 mgFilm-coated tablets | 49048749/7.5/0487Approved 28 July 2025 | Registered | S4 | PIPIL |
| Lipred 80 | 10/20/40/80 mgFilm-coated tablets | 49048849/7.5/0488Approved 28 July 2025 | Registered | S4 | PIPIL |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, read from the product's PI-PIL leaflet.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Atorvastatin calcium trihydrate
S4: Atorvastatin
Consolidated Schedules 06 July 2026, line 5376
Pharmacological class: Serum-cholesterol reducers. (class 7.5)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
(3R,5R)-7-[2-(4-Fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid
Drag to rotate. Structure from PubChem CID 60823.
SAHPRA documents
Schedule Verification
This medication's schedule (S4) has been verified from official SAHPRA documents with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.